Dr. Michael Shapiro received his bachelor’s degree from Harvard University, and his medical degree from the University of Pennsylvania School of Medicine. He did his dermatology residency training at the University of Pennsylvania Health System, and has successfully completed two fellowships. The first fellowship was in cutaneous T-cell lymphoma with Alain H. Rook, MD at the University of Pennsylvania Health System, and the second fellowship was in Mohs micrographic surgery at the University of Colorado with J. Ramsey Mellette, MD.
Dr. Shapiro is a Diplomate of the American Board of Dermatology, and a Fellow of both the American Academy of Dermatology and the American College of Mohs Surgery. He is also a member of the American Society of Dermatologic Surgery. Dr. Shapiro has published over 30 manuscripts and letters to the editor in peer-reviewed academic journals, as well as several book chapters.
PEER REVIEWED PAPERS
Shapiro M, Li LJ, Miller J. Terbinafine-induced neutropenia [Letter]. Br J Dermatol. 140(6):1196-7, 1999 June.
Shapiro M, Johnson B, Elenitsas R. Spiradenoma arising in a nevus sebaceus of Jadassohn: case report and literature review. Am J Dermatopathol. 21(5):462-7, 1999 Oct.
Shapiro M, Jimenez S, Werth VP. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol. 42(2 Pt 1):297-9, 2000 Feb.
Shapiro M, Hark L, Rombeau JL. Proposed association between ileoanal j-pouch perforation and rapid consumption of a high-calorie, high-fiber meal: report of two cases. Dis Colon Rectum. 43(7):1008-11, 2000 Jul.
Shapiro M, Smith KJ, James WD, Giblin WJ, Margolis DJ, Foglia AN, McGinley F, Leyden JJ. The cutaneous microenvironment of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals, with special reference to staphylococcus aureus colonization. J Clin Microbiol. 38(9):3174-8, 2000.
Shapiro M, Mowad C, James WD. Contact dermatitis due to printer’s ink in a milk industry employee: case report and review of the allergen paraphenylenediamine. AmJ Contact Dermatitis. 12(2):109-112, 2001.
Shapiro M, Ward KM, Stern J. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. AIDS Reader 11(4):222-6, 2001 April.
French LE, Shapiro M, Junkins-Hopkins JM, Vittorio CC, Rook AH. Regression of multifocal, skin-restricted, CD30-positive large T-cell lymphoma using interferon alpha and bexarotene therapy. J Am Acad Dermatol 2001;45:914-8.
Rook AH, Zaki MH, Wysocka M, Wood GS, Duvic M, Showe LC, Foss F, Shapiro M, Kuzel TM, Olsen EA, Vonderheid EC, LaLiberte R, Sherman ML. The role for interleukin-12 therapy of cutaneous T cell lymphoma. Annals of the New York Academy of Sciences 2001; 941:177-84.
Vittorio CC, Rook AH, French LE, Shapiro M, Lehrer MS, Junkins-Hopkins JM. Therapeutic advances in biological response modifiers in the treatment of cutaneous T-cell lymphoma. BioDrugs 2001;15(7):431-7.
McGinnis KS, Shapiro M, Junkins-Hopkins JM, Smith M, Lessin SR, Vittorio CC, Rook AH. Denileukin diftitox (Ontak?) for the treatment of panniculitic lymphoma. Arch Dermatol 2002;138(6):740-2.
Taylor AR, Vergilio J-A, Shapiro M, Raizen D, Hunt J, McGrath C, Rook AH, Bagg A. T-cell receptor ?-chain gene PCR to diagnose CNS involvement by cutaneous Tcell lymphoma. J Mol Diagnostics 2002;4:118-20.
Shapiro M, Yun M, Junkins-Hopkins JM, Vittorio CC, Schulman N, Saidman BH, Fried RG, Rook AH, Alavi A. Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography (FDG-PET) in patients with cutaneous T-cell and B-cell lymphomas. J Am Acad Dermatol 2002;47(4):623-8.
Shapiro M, Rook AH, Lehrer MS, Junkins-Hopkins JM, French LE, Vittorio CC. Novel multi-modality biologic response modifier therapy, including bexarotene (Targretin?) and psoralen and long-wave ultraviolet light A (PUVA), for a patient with stage IVa cutaneous T-cell lymphoma (CTCL). J Am Acad Dermatol 2002;47:956-61.
Vittorio CC, Junkins-Hopkins JM, McGinnis KS, Shapiro M, Wysocka M, Zaki MH, French LE, Rook AH. New biologic agents for the treatment of cutaneous T-cell lymphoma.Recent Results in Cancer Research 2002; 160:321-8.
Wysocka M, Zaki MH, French LE, Chehimi J, Shapiro M, Everetts SE, McGinnis KS, Montaner L, Rook AH. Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 2002;100:3287-94.
French LE, Alcindor T, Shapiro M, Margolis DJ, Porter D, Leonard DGB, Rook AH, Foss F. Identification of amplified clonal T-cell population in the blood of patients with chronic graft versus host disease: positive correlation with response to photopheresis. Bone Marrow Transplantation 2002;30:509-15.
Jih DM, Shapiro M, James WD, Levin M, Gelfand J, Williams PT, Oakey RJ, Fakharzadeh S, Seykora JT. Familial basaloid follicular hamartoma: lesional characterization and review of the literature. Am J Dermatopathol 2003;25:130-7.
McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM. Psoralen plus long-wave ultraviolet light A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.Arch Dermatol 2003;139:771-5.
Katz KA, Hivnor CM, Geist DE, Shapiro M, Ming ME, Werth VP. Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions. Arch Dermatol2003;139:991-3.
Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ. Complete remission in advanced blastic NKcell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen. Am JHematology 2003;74:46-51.
Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH. Extracorporeal photopheresis and multi-modality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma. J Cutan Med Surg 2003 Sep 9.
French LE, Shapiro M, Junkins-Hopkins JM, Wolfe JT, Rook AH. Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin-5 and inhibition by interferon alfa. J Am Acad Dermatol2003;49:1170-4.
Hivnor C, Shapiro M, Shepard J, Vittorio CC. Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV. Arch Dermatol 2004;140:13-4.
McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC: Low dose oral bexarotene in combination with low dose interferon alpha in the treatment of cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms.J Amer Acad Dermatol 2004;50:375-379.
Shapiro M, Sosis AC, Junkins-Hopkins JM, Werth VP. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus in a genetically predisposed individual. Int J Dermatol 2004;43:87-94.
Shapiro M, James WD, Kessler R, Lazorik FC, Katz KA, Tam J, Nieves DS, Miller JJ. Comparison of skin biopsy triage decisions by store-and-forward teledermatology and face-to-face dermatology in 49 patients with pigmented lesions and neoplasms. Arch Dermatol 2004;140:525-528.
Shapiro M, Chren M-M, Levy RM, Elder DE, LeBoit PE, Mihm MC, Margolis DJ, Gimotty PA, Ming ME. Variability in nomenclature used for nevi with architectural Disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol 2004;31:523-30.
Seronegative secondary syphilis in two patients co-infected with human immunodeficiency virus. Kingston AA, Vujevich J, Shapiro M, Hivnor CM, Jukic DM, Junkins-Hopkins JM, Jih DM, Kostman JR, James WD. Arch Dermatol 2005;141:431-3.
Eruptive disseminated Spitz nevi. Levy RM, Ming ME, Shapiro M, Tucker M, Guerry D 4th, Cirillo-Hyland VA, Elenitsas R. J Am Acad Dermatol 2007.
Shapiro M, Werth VP. Cutaneous infectious of the head and neck. Facial Plast SurgClin N Am 2003;11:165-73.
Dermatology Secrets, pending. Chapters on Mohs surgery and Rare malignant tumors of the skin.
LETTERS TO THE EDITOR
Rook AH, Shapiro M. Cutaneous squamous-cell carcinoma [Letter to the editor]. N Engl J Med. 345(4):296, July 26, 2001.
1) Ming ME, Shapiro M, Elder DE, Mihm MC, Chren MM. There is wide variation among dermatopathologists and dermatologists regarding the clinical significance and proper treatment of dysplastic nevi [abstract]. J Cutan Pathol 2003;30:75.
Shapiro M, Ming ME, Elder DE, Mihm MC, Margolis DJ, Gimotty PA, Chren MM. Investigation of the nomenclature used for microscopically dysplastic nevi [abstract]. J Cutan Pathol 2003;30:75-76.
Shapiro M, Tucker MA, Cirillo-Hyland V, Elenitsas R. Eruptive disseminated Spitz nevi [abstract]. J Cutan Pathol 2003;30:43-44.
Levy RM, Shapiro M, Ming ME. Effect of personalization and candy incentive on response rate for a mailed survey of dermatologists [abstract]. J Invest Dermatol2003;121:0426.
Levy RM, Shapiro M, Ming ME. Effect of personalization and candy incentive on response rate for a mailed survey of dermatologists [abstract]. J Dermatological Science [www.intl.elsevierhealth.com/journals/jods] 2003:0426.
Shapiro M, James WD, Kessler R, Lazorik FC, Tam J, Nieves DS, Katz KA, Miller JJ. Comparison of skin biopsy triage decisions by store-and-forward teledermatology and face-to-face dermatology in 49 patients with pigmented lesions and neoplasms [abstract]. J Invest Dermatol 2003;121:0441.
Shapiro M, James WD, Kessler R, Lazorik FC, Tam J, Nieves DS, Katz KA, Miller JJ. Comparison of skin biopsy triage decisions by store-and-forward teledermatology and face-to-face dermatology in 49 patients with pigmented lesions and neoplasms [abstract]. J Dermatological Science [www.intl.elsevierhealth.com/journals/jods] 2003:0441.
Richardson SK, Vittorio CC, McGinnis KS, Shapiro M, Rook AH. High clinical response rate with multi-modality immunomodulatory therapy for S?zary syndrome [abstract]. J Invest Dermatol 2003;121:1209.
Richardson SK, Vittorio CC, McGinnis KS, Shapiro M, Rook AH. High clinical response rate with multi-modality immunomodulatory therapy for S?zary syndrome [abstract]. J Dermatological Science [www.intl.elsevierhealth.com/journals/jods] 2003:1207.